LY96 and psoriasis: Specifically, the LY96 rs11465996 (C > G) polymorphism has been evaluated in a cohort of patients from Denmark diagnosed with moderate-to-severe psoriasis and treated with anti-TNF drugs and UTK (n = 478), showing that patients carrying the LY96 rs11465996-C allele had a worse response to UTK (ΔPASI at 3 months) (n = 230) (OR = 0.33, CI95% = 0.15–0.71, p = 0.0044, q = 0.19) [71].